ID1-induced p16/IL6 axis activation contributes to the resistant of hepatocellular carcinoma cells to sorafenib

Leilei Niu(Chinese University of Hong Kong), Paul B.S. Lai(University of Hong Kong)

Cell Death and Disease

August 28, 2018

10.1038/s41419-018-0926-x

Cited by 26

Related Papers

Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients

|Proceedings of the National Academy of Sciences|2015|755

Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system

|Cancer|2002|584

CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint Blockade

|Cancer Discovery|2020|143

HBx mutants differentially affect the activation of hypoxia-inducible factor-1α in hepatocellular carcinoma

|British Journal of Cancer|2013|54

Cytochrome P450 1A2 Metabolizes 17β-Estradiol to Suppress Hepatocellular Carcinoma

|PLoS ONE|2016|49